| |
| |
|
| Insider
Information: |
Patou Gary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
37,714 |
|
|
Indirect Shares
|
5,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$19,593 |
|
|
| Total
Shares |
43,318 |
|
|
| Total
Value |
$19,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
14,141 |
2004-11-02 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2014-08-07 |
0 |
2014-08-07 |
702 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
150 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-27 |
4 |
OE |
$0.07 |
$1,050 |
D/D |
15,000 |
407,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-10-25 |
4 |
OE |
$0.07 |
$1,050 |
D/D |
15,000 |
407,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-10-31 |
4 |
OE |
$0.07 |
$1,050 |
D/D |
15,000 |
407,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-11-17 |
4 |
OE |
$0.07 |
$1,050 |
D/D |
15,000 |
407,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-29 |
4 |
OE |
$0.07 |
$1,283 |
D/D |
18,334 |
371,182 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-09-06 |
4 |
OE |
$0.07 |
$1,400 |
D/D |
20,000 |
412,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-10-20 |
4 |
OE |
$0.07 |
$1,400 |
D/D |
20,000 |
412,856 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-26 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
364,126 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-31 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
366,348 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-02-24 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
389,681 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-02-25 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
391,903 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-31 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
377,460 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-08 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
394,522 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-11-02 |
4 |
AS |
$3.50 |
$1,750 |
D/D |
(500) |
12,253 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-22 |
4 |
OE |
$0.07 |
$1,944 |
D/D |
27,778 |
397,300 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-21 |
4 |
OE |
$0.07 |
$1,944 |
D/D |
27,778 |
402,856 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-03-17 |
4 |
A |
$19.49 |
$1,949 |
I/I |
100 |
100 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-29 |
4 |
OE |
$0.07 |
$3,588 |
D/D |
51,256 |
94,603 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
D |
$34.37 |
$4,124 |
D/D |
(120) |
25,510 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2022-11-25 |
4 |
OE |
$2.68 |
$5,513 |
D/D |
2,057 |
25,630 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-12-14 |
4 |
OE |
$3.07 |
$6,315 |
D/D |
2,057 |
19,459 |
0 |
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-20 |
4 |
OE |
$1.18 |
$6,556 |
D/D |
5,556 |
372,855 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-12-04 |
4 |
OE |
$3.56 |
$7,323 |
D/D |
2,057 |
21,516 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-12-08 |
4 |
OE |
$3.67 |
$7,549 |
D/D |
2,057 |
25,630 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2020-10-28 |
4 |
OE |
$3.76 |
$7,734 |
D/D |
2,057 |
23,573 |
0 |
- |
|
150 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
